Dr. Dayaker Gagadam, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy, Suite 208, Burleson, TX 76028 Phone: 817-293-3000 Fax: 817-293-3291 |
Dr. Jason Andrew Seiden, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy, Suite 104, Burleson, TX 76028 Phone: 817-293-1200 Fax: 817-293-1202 |
Dereje Ayo, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 11803 South Fwy Ste 311, Burleson, TX 76028 Phone: 817-568-8411 Fax: 817-568-8414 |
News Archive
Clean sleeping has been touted as the new wellness trend for 2017, so end restless nights for the whole family with BetterYou magnesium, recently named ‘Best Sleep Brand' at the Mumii Family Awards 2017.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that the consortium, led by Apitope, which includes GSK Vaccines, Quintiles and KWS Biotest Limited, has been awarded prestigious Framework Programme 7 Health Innovation funding by the European Commission to develop its Graves' disease therapeutic vaccine, including a Phase I first-in-man study in Graves' disease patients.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
An interesting study published on the preprint server medRxiv in November 2020, dealing not with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is the cause of the COVID-19 pandemic, but with the publications that have appeared as a consequence of the outbreak, comparing them with the similar trove of publications that followed the Zika virus outbreak in 2016.
› Verified 3 days ago